Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose Versus Standard-dose Remimazolam for Prevention of Emergence Agitation After Nasal Surgery
NCT07740655Phase 4Not yet recruiting
- Sponsor
- Jeju National University School of Medicine
- Start
- Jul 2026
- Primary completion
- Jul 2027
- Countries
- 1
01
Overview
A Phase 4 trial of remimazolam in Emergence agitation (EA), sponsored by Jeju National University School of Medicine. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
Emergence agitation (EA)
Beyond the preview
Go deeper on NCT07740655.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07740655.